Citron Research says Valeant Pharma (VRX) has better chance than HLF of 'going to $0'

Citron Research says Valeant Pharma (NYSE: VRX) has better chance than HLF of 'going to $0'. Citron said it will have more details on Monday. Calls company 'dirtier' than anyone has reported.

$VRX has a better chance of going to 0 than $HLF EVER will. Citron to update full story on Monday. Dirtier than anyone has reported!!

— Citron Research (@CitronResearch) October 30, 2015

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Regenxbio shares jump after FDA agrees to reverse drug rejection
• Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters